{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:08:10Z","timestamp":1772759290268,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Insitutes of Health Research","doi-asserted-by":"crossref","award":["Foundation award"],"award-info":[{"award-number":["Foundation award"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["T-000353"],"award-info":[{"award-number":["T-000353"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["4530"],"award-info":[{"award-number":["4530"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0680-1","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T08:03:16Z","timestamp":1521014596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Complex genetic architecture in severe hypobetalipoproteinemia"],"prefix":"10.1186","volume":"17","author":[{"given":"Linda R.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10545-013-9665-4","volume":"37","author":"J Lee","year":"2014","unstructured":"Lee J, Hegele RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis. 2014;37:333\u20139.","journal-title":"J Inherit Metab Dis"},{"key":"680_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-3-19","volume":"3","author":"R Zamel","year":"2008","unstructured":"Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis. 2008;3:19.","journal-title":"Orphanet J Rare Dis"},{"key":"680_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","volume":"25","author":"FK Welty","year":"2014","unstructured":"Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol. 2014;25:161\u20138.","journal-title":"Curr Opin Lipidol"},{"key":"680_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.ATV.17.5.881","volume":"17","author":"FK Welty","year":"1997","unstructured":"Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67\/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997;17:881\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"680_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O'roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452\u20137.","journal-title":"Nucleic Acids Res"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<294::AID-HUMU14>3.0.CO;2-E","volume":"15","author":"J Wang","year":"2000","unstructured":"Wang J, Hegele RA. Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia. Hum Mutat. 2000;15:294\u20135.","journal-title":"Hum Mutat"},{"key":"680_CR8","doi-asserted-by":"crossref","unstructured":"Al-Shali K, Wang J, Rosen F, Hegele RA. Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia. Clin Genet. 2003;63:135\u20138.","DOI":"10.1046\/j.0009-9163.2002.00175.x"},{"key":"680_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1194\/jlr.M031658","volume":"54","author":"I Khatun","year":"2013","unstructured":"Khatun I, Walsh MT, Hussain MM. Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia. J Lipid Res. 2013;54:1541\u20139.","journal-title":"J Lipid Res"},{"key":"680_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-12-387025-4.00004-2","volume":"54","author":"P Tarugi","year":"2011","unstructured":"Tarugi P, Averna M. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem. 2011;54:81\u2013107.","journal-title":"Adv Clin Chem"},{"key":"680_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","volume":"20","author":"N Berriot-Varoqueaux","year":"2000","unstructured":"Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr. 2000;20:663\u201397.","journal-title":"Annu Rev Nutr"},{"key":"680_CR12","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1172\/JCI113026","volume":"79","author":"SG Young","year":"1987","unstructured":"Young SG, Bertics SJ, Curtiss LK, Dubois BW, Witztum JL. Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J Clin Invest. 1987;79:1842\u201351.","journal-title":"J Clin Invest"},{"key":"680_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCGENETICS.111.960674","volume":"5","author":"L Pisciotta","year":"2012","unstructured":"Pisciotta L, Favari E, Magnolo L, Simonelli S, Adorni MP, Sallo R, et al. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ Cardiovasc Genet. 2012;5:42\u201350.","journal-title":"Circ Cardiovasc Genet"},{"issue":"Suppl 1","key":"680_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/BF01800666","volume":"8","author":"DP Muller","year":"1985","unstructured":"Muller DP, Lloyd JK, Wolff OH. The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J Inherit Metab Dis. 1985;8(Suppl 1):88\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"680_CR15","first-page":"41","volume":"132","author":"RA Hegele","year":"1985","unstructured":"Hegele RA, Angel A. Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy. Can Med Assoc J. 1985;132:41\u20134.","journal-title":"Can Med Assoc J"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100:267\u201380.","journal-title":"Am J Hum Genet"},{"key":"680_CR17","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1172\/JCI42703","volume":"120","author":"S Zeissig","year":"2010","unstructured":"Zeissig S, Dougan SK, Barral DC, Junker Y, Chen Z, Kaser A, et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest. 2010;120:2889\u201399.","journal-title":"J Clin Invest"},{"key":"680_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"680_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000334984","volume":"73","author":"MC Lopes","year":"2012","unstructured":"Lopes MC, Joyce C, Ritchie GR, John SL, Cunningham F, Asimit J, et al. A combined functional annotation score for non-synonymous variants. Hum Hered. 2012;73:47\u201351.","journal-title":"Hum Hered"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0680-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T17:09:46Z","timestamp":1570900186000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0680-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0680-1","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"3 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clinical data and DNA from family members were obtained with informed consent under a protocol approved by the Western University Institutional Review Board (number 07290E). All subjects provided informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The proband provided signed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RAH has received honoraria for membership on advisory boards and speakers\u2019 bureaus for Aegerion, Amgen, Gemphire, Lilly, Merck, Pfizer, Regeneron, Sanofi and Valeant. LRW and ADM have no disclosures to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}